What to know about the ruling blocking the mailing of abortion pill mifepristone
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone.
A panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that the abortion pill be distributed only in-person at clinics.
Since the Supreme Court’s 2022 ruling that overturned Roe v.
Wade and allowed enforcement of abortion bans, prescriptions by mail have become a major way that abortions are provided — including to states where bans are in place.
The ruling is expected to be appealed to the U.S. Supreme Court.
Emergency appeal on abortion pills
- An appeals court has ended telemedicine abortion pill access nationally, for now NPR —
- US appeals court temporarily halts mail delivery of abortion pill The Straits Times —
- Court blocks abortion pills prescribed through the mail UPI —
- Federal appeals court blocks mailing of abortion pills in ruling with nationwide effect Fox News —
- Appeals Court Curtails Access to Mail-Order Abortion Pills Wall Street Journal —